ArticleThoracic cancer2018

Evaluation of calculating carboplatin dosage in carboplatin-pemetrexed therapy as the first-line therapy for Chinese patients with advanced lung adenocarcinoma.

Yixiang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.